Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseLife at Premier By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 What is Real-World Data and Evidence and How It Can Facilitate Clinical Development By Nach Davé September 19, 2022 Clinical ResearchPhase 1 - Phase 4 How to Select Drugs to Switch from Rx to OTC By Colleen Coleman September 12, 2022 Patient and Stakeholder Engagement Seasonality: A factor for successful patient recruitment By Nikhil Bhanumathi September 6, 2022 Clinical ResearchPhase 1 - Phase 4 Patient Enrollment and Retention: Overcoming Challenges in Observational Research By Colleen Coleman August 29, 2022 Clinical ResearchPhase 1 - Phase 4 7 Factors Fueling the Growth of Oncology Trials in Asia-Pacific By Ashish Jain August 15, 2022 Clinical ResearchPhase 1 - Phase 4 Conducting Successful Oncology Trials in the Asia-Pacific Region By Ashish Jain August 8, 2022 Previous 1 …8 9 10 11 12 … 57 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today